Inhibition of growth of ES-2 human ovarian cancers by bombesin antagonist RC-3095, and luteinizing hormone-releasing hormone antagonist Cetrorelix

Cancer Letters

Volumn 171, Issue 1, 2001, Pages 37-45

  Chatzistamou, Ioulia ^a,b   Schally, Andrew V ^a,b   Szepeshazi, Karoly ^a,b   Groot, Kate ^a   Hebert, Francine ^a   Arencibia, Jose M ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bombesin gastrin releasing peptide; Cancer therapy; Luteinizing hormone releasing hormone; Ovarian tumors

Indexed keywords

BOMBESIN ANTAGONIST; CETRORELIX; GONADORELIN ANTAGONIST; RC 3095;

ADULT; ANIMAL TISSUE; ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG CONCENTRATION; DRUG DOSE; DRUG EFFECT; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA, CLEAR CELL; ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; BOMBESIN; FEMALE; GASTRIN-RELEASING PEPTIDE; GENE EXPRESSION REGULATION, NEOPLASTIC; GONADOTROPIN-RELEASING HORMONE; HUMANS; LUTEINIZING HORMONE; MICE; MICE, NUDE; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PEPTIDE FRAGMENTS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, BOMBESIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SPECIFIC PATHOGEN-FREE ORGANISMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035964475     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00543-2     Document Type: Article

References (38)

1. Cancer statistics
2. Selective stimulation of small cell lung cancer
3. Growth factor and peptide receptors in small cell lung cancer
4. Production of gastrin-releasing peptide by a non-small cell lung carcinoma cell line adapted to serum-free and growth factor-free conditions
5. Bombesin stimulates growth of human prostatic cancer cells in vitro
6. Stimulation by bombesin and inhibition by bombesin/gastrin releasing peptide antagonist RC-3950 of growth of human breast cancer cell lines
7. Bombesin may stimulate proliferation of human pancreatic cancer cells through an autocrine pathway
8. Gastrin-releasing peptide receptors in the human prostate: Relation to neoplastic transformation
9. Inhibition of growth of human malignant glioblastoma in nude mice by antagonists of bombesin/gastrin-releasing peptide
10. Novel expression and regulation of gastrin gene in human ovarian cancer cell line, SW626
11. The presence of receptors for bombesin/GRP and mRNA for three receptor subtypes in human ovarian epithelial cancers
12. Hypothalamic and other peptide hormones
13. Bombesin-like peptides: Of ligands and receptors
14. Cloning of a receptor for amphibian [Phe13]bombesin distinct from the receptor for gastrin-releasing peptide: Identification of a fourth bombesin receptor subtype (BB4)
15. 2 or its derivatives
16. Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice
17. Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinizing hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II
18. Growth inhibition of estrogen-dependent and estrogen-independent MXT mammary cancers in mice by the bombesin and gastrin-releasing peptide antagonist RC-3095
19. A single in vivo administration of bombesin antagonist RC-3095 reduces the levels and mRNA expression of epidermal growth factor receptors in MXT mouse mammary cancers
20. Inhibitory effect of bombesin/gastrin-releasing peptide (GRP) antagonists RC-3950-II and RC-3095 on MCF7-MIII human breast cancer xenografts in nude mice
21. Inhibition of growth of MDA-MB-231 human breast cancer xenografts in nude mice by bombesin/gastrin-releasing peptide (GRP) antagonists RC-3940-II and RC-3095
22. Inhibition of growth of OV-1063 human epithelial ovarian cancers and c-jun and c-fos oncogene expression by bombesin antagonists
23. Bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma
24. Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro
25. Bombesin antagonists inhibit in vitro and in vivo growth of human gastric cancer and binding of bombesin to its receptors
26. Inhibition of growth of OV-1063 human epithelial ovarian cancer xenografts in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75
27. 6]luteinizing hormone releasing hormone and epidermal growth factor in human ovarian cancer
28. Luteinizing hormone-releasing hormone analogs: Their impact on the control of tumorigenesis
29. Expression of mRNA for luteinizing hormone-releasing hormone receptors and epidermal growth factor receptors in human cancer cell lines
30. Luteinizing hormone-releasing hormone as an autocrine growth factor in ES-2 ovarian cancer cell line
31. Biological effects and receptor binding affinities of new pseudononapeptide bombesin/GRP receptor antagonists with N-terminal D-Trp or D-Tpi
32. New antagonists of LH-RH: II. Inhibition and potentiation of LH-RH by closely related analogues
33. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin
34. Determination of subcutaneous tumor size in athymic (nude) mice
35. Inhibitory effect of bombesin/GRP antagonist RC-3095 and high dose of somatostatin analog RC-160 on nitrosamine-induced pancreatic cancers in hamsters
36. Expression of somatostatin receptor (SSTR) subtypes in pituitary adenomas: Quantitative analysis of SSTR2 mRNA by reverse transcription-polymerase chain reaction
37. Inhibition of growth of MDA-MB-468 estrogen-independent human breast carcinoma by bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II